UBS Group’s BrightSpring Health Services BTSG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$23.6M Sell
553,660
-90,800
-14% -$3.66M ﹤0.01% 2406
2025
Q4
$24.1M Sell
644,460
-20,266
-3% -$680K ﹤0.01% 2405
2025
Q3
$19.6M Sell
664,726
-52,885
-7% -$1.23M ﹤0.01% 2590
2025
Q2
$16.9M Buy
717,611
+498,197
+227% +$10.4M ﹤0.01% 2548
2025
Q1
$3.97M Sell
219,414
-105,521
-32% -$2.07M ﹤0.01% 4025
2024
Q4
$5.53M Buy
324,935
+198,229
+156% +$3.43M ﹤0.01% 3729
2024
Q3
$1.86M Buy
126,706
+35,649
+39% +$447K ﹤0.01% 4066
2024
Q2
$1.03M Buy
91,057
+36,838
+68% +$402K ﹤0.01% 4398
2024
Q1
$589K Buy
+54,219
New +$542K ﹤0.01% 5068

Other funds holding BTSG

UBS Group's BTSG Position: Q1 2026 in Review

UBS Group reduced its BrightSpring Health Services (BTSG) stake by 14% in Q1 2026, selling an estimated $3.66M and leaving 553,660 shares worth $23.6M. The position accounts for ﹤0.01% of the portfolio, ranked #2406.

UBS Group first reported a position in BTSG in Q1 2024 and has held it in 9 quarters since. The position peaked at $24.1M in Q4 2025. 335 funds tracked by Wall St. Rank hold BTSG as of Q1 2026.

  • UBS Group held 553,660 shares of BrightSpring Health Services worth $23.6M as of Q1 2026.
  • UBS Group sold 90,800 BrightSpring Health Services shares in Q1 2026, an estimated $3.66M.
  • BrightSpring Health Services made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #2406 holding.
  • UBS Group first reported a position in BrightSpring Health Services in Q1 2024 and has held it in 9 quarters since.
  • UBS Group's BrightSpring Health Services position peaked at $24.1M in Q4 2025.
  • 335 funds tracked by Wall St. Rank held BrightSpring Health Services as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.